Imfinzi reduced the risk of distant metastases and death from bladder cancer vs. neoadjuvant chemotherapy alone
The safety profile of Opdualag observed in this analysis was consistent with the known profiles of nivolumab and relatlimab
Branded formulation business continues to perform well across domestic and export markets
These solutions combine scientifically or clinically validated, regulatory-approved probiotic strains with precise dosing
Based on DESTINY-Breast06 Phase III trial results which showed Enhertu demonstrated superiority vs. chemotherapy with a median progression-free survival of more than one year
The company ensures a reliable and strong portfolio at competitive prices without compromising on excellent quality
Regulatory filings underway for a third indication for darolutamide in prostate cancer, for finerenone in a common form of heart failure, and acoramidis in transthyretin amyloid
Dr. Smith brings 30 years of clinical and translational research experience in obesity, diabetes, and metabolism with over 300 scientific publications
This product is an oral SYK inhibitor and suppresses platelet destruction by macrophages and platelet depletion
Data from IDSP does not indicate any unusual rise in ILI/SARI cases anywhere in the country
Subscribe To Our Newsletter & Stay Updated
